July 17, 2017 Cell Analysis Tools Life Science Tools PR/Corporate

Sphere Fluidics Limited and Partners Win Major InnovateUK Grant to Develop the World’s First Desktop Genome Editing System

CAMBRIDGE, England, July 17, 2017 /PRNewswire/ — Sphere Fluidics Limited and their partners have just won a $1.25 million grant to develop a novel automated single cell genome engineering platform. The grant syndicate also includes Horizon Discovery (UK), Twist Bioscience (US) and the University of Edinburgh (UK). The grant was an Open Innovation Grant from InnovateUK with participation open to companies in... Read more

July 17, 2017 Lab Top-10 Life Science Tools Product Launch

Agilent Technologies Introduces New High-Sensitivity NGS Target Enrichment Solution

New Solution Streamlines Workflow and Eliminates Sequencing Errors SANTA CLARA, Calif., July 17, 2017 Agilent Technologies Inc. (NYSE: A) today introduced its newest next-generation sequencing (NGS) library prep solution — Agilent SureSelectXT HS — a complete target enrichment research solution that provides total workflow management for laboratories, from QC to target enrichment, to analysis and... Read more

July 11, 2017 Acad, Gov/Utilities Informatics & Software Life Science Tools M&A, Partnerships PR/Corporate

Kailos Genetics Announces Strategic Investment and Partnership with In-Q-Tel

Partnership will further develop Kailos’ leading-edge next-generation sequencing solutions for the intelligence community July 11, 2017 09:00 AM Eastern Daylight Time HUNTSVILLE, Ala.–(BUSINESS WIRE)–Kailos Genetics, a personalized medicine company offering a leading-edge suite of tools for next-generation sequencing (NGS)-based assays, today announced a strategic partnership with and investment from In-Q-Tel, Inc. (IQT). IQT is the... Read more

July 11, 2017 Life Science Tools M&A, Partnerships

Quintara Biosciences Partners with Twist Bioscience to Launch New Gene Fragment and Cloning Services, qBlocks and qGenes

San Francisco, CA – July 11, 2017 – Quintara Biosciences, a leader in DNA sequencing and molecular biology, today announced a new partnership with Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, to launch two new services: qBlock Gene Fragments and qGene DNA cloning.  This partnership leverages the high throughput and... Read more

July 11, 2017 Life Science Tools M&A, Partnerships

Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

SAN FRANCISCO, Calif. – July 11, 2017 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced that it signed a non-exclusive agreement with Synbio Technologies. The companies will partner their respective capabilities to provide customers with access to long-length genes up to 70 kilobases. “We are thrilled to... Read more

July 11, 2017 Life Science Tools PR/Corporate

SeqLL Awarded SBIR to Advance the Development of Direct RNA Sequencing (DRS™) Technology

July 11, 2017 08:36 AM Pacific Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–SeqLL, LLC announced today that it has been awarded a Phase I SBIR grant in the amount of $223,465 by the NIH/National Human Genome Research Institute to advance the development of Direct RNA Sequencing (DRS™) technology on SeqLL’s True Single Molecule Sequencing (tSMS™) platform. The... Read more

July 6, 2017 Clinical Research/Diagn. Life Science Tools

Promega Intends to Seek FDA Approval for Microsatellite Instability Assay to Assist in Strategic Cancer Decisions

MADISON, WI USA (July 6, 2017) Promega Corporation intends to seek US Food and Drug Administration approval and CE-IVD marking for a commercially available Microsatellite Instability (MSI) assay to assist oncologists and pathologists in determining colorectal cancer decisions. MSI status is a measure of mismatch-repair deficiency commonly found in solid tumors. In addition to the colorectal... Read more

July 3, 2017 Clinical Research/Diagn. Life Science Tools

Roche expands cobas Liat PCR System menu with launch of cobas MRSA/SA test to target healthcare-associated infections

Basel, 03 July 2017 Roche expands cobas Liat PCR System menu with launch of cobas MRSA/SA test to target healthcare-associated infections With more than 150,000 affected patients per year, MRSA and SA are major sources of healthcare and community associated infections in Europe Fast detection reduces the risk of transmission within the hospital, but classical... Read more

June 29, 2017 Clinical Research/Diagn. Lab Top-10 Life Science Tools

Illumina Announces FDA-approved Next-Generation Sequencing Cancer Companion Diagnostic Test Kit

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced its Extended RAS Panel, an FDA-approved next-generation sequencing (NGS) kit that meets the newly published guidelines for evaluation of colorectal cancer from the American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), the Association for Molecular Pathology (AMP), and the American Society of Clinical Oncology... Read more